Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Interest Expenses (2016)

Historic Interest Expenses for Voyager Therapeutics (VYGR) over the last 2 years, with Q2 2016 value amounting to -$283000.0.

  • Voyager Therapeutics' Interest Expenses fell 29305.56% to -$283000.0 in Q2 2016 from the same period last year, while for Mar 2017 it was -$283000.0, marking a year-over-year increase of 3752.76%. This contributed to the annual value of $9.8 million for FY2015, which is 40000.0% up from last year.
  • Per Voyager Therapeutics' latest filing, its Interest Expenses stood at -$283000.0 for Q2 2016, which was down 29305.56% from -$279000.0 recorded in Q1 2016.
  • Voyager Therapeutics' 5-year Interest Expenses high stood at $9.7 million for Q1 2015, and its period low was -$283000.0 during Q2 2016.